A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets

Diabetologia

Volumn 55, Issue 12, 2012, Pages 3262-3272

  Marchetti, P ^a,b   Lupi, R ^b   Bugliani, M ^a   Kirkpatrick, C L ^c   Sebastiani, G ^d,e   Grieco, F A ^d,e   Guerra, S Del ^a   D'Aleo, V ^a   Piro, S ^f   Marselli, L ^a   Boggi, U ^b   Filipponi, F ^b   Tinti, L ^g   Salvini, L ^g   Wollheim, C B ^c   Purrello, F ^f   Dotta, F ^d,e  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF SIENA   (Italy)

^e Fondazione Umberto Di Mario   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g Toscana Life Sciences Foundation   (Italy)

Author keywords

Alpha cells; GLP 1; Glucagon; Pancreatic islets

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; INSULIN; PROPROTEIN CONVERTASE 1;

ARTICLE; CELL FRACTIONATION; CELL SELECTION; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BINDING; FEMALE; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE LEVEL;

DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MASS SPECTROMETRY; MIDDLE AGED; PANCREAS;

EID: 84868193842     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2716-9     Document Type: Article

References (50)

1. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131-2157
2. Ahrén B (2007) GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors. Curr Diab Rep 7:340-347
3. Mathieu C, Bollaerts K (2007) Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors. Int J Clin Pract Suppl 154:29-37
4. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Orskov C (1994) Proglucagon processing in porcine and human pancreas. J Biol Chem 269:18827-18833
5. Vilsbøll T, Holst JJ (2004) Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47:357-366
6. Diamant M, Van Gaal L, Stranks S et al (2010) Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. Lancet 375:2234-2243
7. Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A (2011) Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database Syst Rev (5), Art. no.: CD006423. doi:10.1002/14651858.CD006423.pub2
8. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439
9. Uttenthal LO, Ghiglione M, George SK, Bishop AE, Polak JM, Bloom SR (1985) Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. J Clin Endocrinol Metab 61:472-479
10. Varndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM (1985) Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 33:1080-1086
11. Mojsov S, Kopczynski MG, Habener JF (1990) Both amidated and nonamidates forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem 265:8001-8008
12. Heller RS, Aponte GW (1995) Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7-36)amide. Am J Physiol 269:G853-G860
13. Kreymann B, Ghatei MA, Domin J, Kanse S, Bloom SR (1991) Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut. Endocrinology 129:1001-1005
14. Masur K, Tibaduiza EC, Chen C, Ligon B, Beinborn M (2005) Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function. Mol Endocrinol 19:1373-1382
15. Thyssen S, Arany E, Hill DJ (2006) Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 147:2346-2356
16. Whalley NM, Pritchard LE, Smith DM, White A (2011) Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? J Endocrinol 211:99-106
17. Hansen AM, Bödvarsdottir TB, Nordestgaard DN et al (2011) Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus -an adaptive response to hyperglycaemia? Diabetologia 54:1379-1387
18. Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481-1489
19. Tancredi M, Marselli L, Lencioni C et al (2011) Histopathology and ex vivo insulin secretion of pancreatic islets in gestational diabetes: a case report. Islets 3:231-233
20. Ghiglione M, Uttenthal LO, Koch C (1993) Monoclonal antibodies to glucagon-like peptide-1. Digestion 54:396-397
21. Zhang H, Li J, Liang X, Luo Y, Zen K, Zhang CY (2012) Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide-1 (GLP-1) secretion. J Mol Endocrinol 48:151-158
22. Igoillo-Esteve M, Marselli L, Cunha DA et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395-1405
23. Marchetti P, Bugliani M, Lupi R et al (2007) The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50:2486-2494
24. Di Poto C, Iadarola P, Bardoni AM et al (2007) 2-DE and MALDITOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis. Electrophoresis 28:4320-4329
25. Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91-100
26. Kirkpatrick CL, Marchetti P, Purrel F et al (2010) Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors. PLoS One 5:e11053
27. Lukowiak B, Vandewalle B, Riachy R et al (2001) Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49:519-528
28. Davidson HW (2004) (Pro)Insulin processing: a historical perspective. Cell Biochem Biophys 40(3 Suppl):143-158
29. Holst JJ (2010) Glucagon and glucagon-like peptides 1 and 2. Results Probl Cell Differ 50:121-135
30. Jensen PB, Larsen PJ, Karlsen C, Jensen HI, Holst JJ, Madsen OD (2011) Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia. Diabetes Obes Metab 13(Suppl 1):60-68
31. Portela-Gomes GM, Grimelius L, Stridsberg M (2008) Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas. Regul Pept 146:117-124
32. Bosco D, Armanet M, Morel P et al (2010) Unique arrangement of alpha-and beta-cells in human islets of Langerhans. Diabetes 59:1202-1210
33. Wilson ME, Kalamaras JA, German MS (2002) Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev 115:171-176
34. Kilimnik G, Kim A, Steiner DF, Friedman TC, Hara M (2010) Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration. Islets 2:149-155
35. Fujita Y, Wideman RD, Asadi A et al (2010) Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alphacells and promotes insulin secretion. Gastroenterology 138:1966-1975
36. De Marinis YZ, Zhang E, Amisten S et al (2010) Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta. Diabetologia 53:717-729
37. Walker JN, Ramracheya R, Zhang Q, Johnson PR, Braun M, Rorsman P (2011) Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diabetes Obes Metab 13 (Suppl 1):95-105
38. Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624-632
39. Henquin JC, Rahier J (2011) Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 54:1720-1725
40. Meier JJ, Ueberberg S, Korbas S, Schneider S (2011) Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass. Am J Physiol Endocrinol Metab 300:E717-E723
41. Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ (2011) Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 54:10-18
42. Toft-Nielsen MB, Damholt MB, Madsbad S et al (2001) Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723
43. Dunning BE, Foley JE, Ahrén B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48:1700-1713
44. Ryskjaer J, Deacon CF, Carr RD et al (2006) Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 155:485-493
45. Mannucci E, Pala L, Ciani S et al (2005) Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48:1168-1172
46. Cnop M, Foufelle F, Velloso LA (2012) Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med 18:59-68
47. Marchetti P, Lupi R, del Guerra S et al (2009) Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 32(Suppl 2):S178-S183
48. Liu Z, Stanojevic V, Avadhani S, Yano T, Habener JF (2011) Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagonlike peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia 54:2067-2076
49. Wideman RD, Yu IL,Webber TD et al (2006) Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1). Proc Natl Acad Sci U S A 103:13468-13473
50. Wideman RD, Covey SD, Webb GC, Drucker DJ, Kieffer TJ (2007) A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice. Diabetes 56:2744-2752